- ►diabetesjournals.org A Ceriello - Diabetes Care, 2009 - Am Diabetes Assoc In the recent HEART2D (Hyperglycemia and its Effect After Acute Myocardial Infarction on Cardiovascular
Outcomes in Patients with Type 2 Diabetes Mellitus) study, published in this issue of Diabetes
Care, Raz et al. (1) try to answer a hotly debated question of the last 10 years: is ... Cited by 3 - Related articles - All 3 versions
L Monnier, C Colette, DR Owens - Diabetes Metab Res Rev, 2009 - interscience.wiley.com The high incidence of atherosclerosis and cardiovascular disease (CVD) is the leading cause
of morbidity and mortality among patients with diabetes. Evidence is accumulating that postprandial
hyperglycaemia is an independent risk factor for diabetes-associated complications and ... Cited by 1 - Related articles - All 2 versions
M Roden - New England Journal of Medicine, 2009 - content.nejm.org Patients with type 2 diabetes have peripheral in- sulin resistance and inadequate insulin secretion
by pancreatic beta cells. During meals, reduced first-phase insulin secretion results in
postpran- dial hyperglycemia and in a 35% decrease in he- patic glycogen storage.1 A ... Related articles - All 5 versions
CME Tracker - medscape.com Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the US population
in 1988-1994 and 2005-2006. Diabetes Care. 2009;32:287-294. Epub 2008 Nov 18. ... Haigh
C. Burden of diagnosed diabetes increased between 1988-1994, 2005-2006. Endocrine ... Related articles - All 6 versions
M Bartnik, F Cosentino - European Heart Journal, 2009 - Eur Soc Cardiology In agreement with large epidemiological studies, 2,9 Dale et al. found a relationship between
updated HbA1c and mortality from IHD during 20 years follow-up, showing a 20% risk increase
per 1% increment of HbA1c. 1 Interestingly, the mortality was even higher in patients ... Related articles - All 3 versions
IT Challenges - members.medscape.com There is substantial evidence that early and aggressive intervention in diabetes is important.
Evidence has suggested that the level of A1C that triggers action is 9%. [18] Given that diabetes
is a progressive disease, there will be a need to advance therapy as time progresses. ... Related articles - Cached
A Statements - medscape.com The goal of this educational activity is to summarize the pathophysiology of type 2 diabetes and
its relationship to the cardiometabolic syndrome. It will highlight current treatment goals for type
2 diabetes, and nonpharmacologic and pharmacologic interventions currently in use. It ... Related articles
CME Tracker - members.medscape.com The reality is that 80% of patients with type 2 diabetes are on some kind of diabetes
medication. Given that many patients on treatment are not at their evidence-based goals suggests
that failure to up-titrate therapy may be the problem. The ADA and the European ... Related articles - Cached
L Monnier, C Colette, E Mas, F Michel, JP Cristol, C … - Diabetologia - Springer Abstract Aims/hypothesis We examined whether type of diabetes and/or insulin treatment can
modulate the impact of sustained hyperglycaemia and glycaemic variability as activators of oxidative
stress. Methods This was an observational study in 139 patients with diabetes, 48 with ...
C Weber, O Schnell - Diabetes Technology & Therapeutics, 2009 - liebertonline.com Abstract There is a growing body of evidence that the sole use of hemoglobin A1c is insufficient
to adequately reflect the metabolic situation of patients with diabetes mellitus. The risk of developing
diabetes-related complications apparently not only depends on the long-term stability of ... Related articles - All 2 versions
